Methods to Improve Adoptive T-Cell Therapy for Melanoma: IFN-γ Enhances Anticancer Responses of Cell Products for Infusion
- 1 February 2013
- journal article
- clinical trial
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 133 (2) , 545-552
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Eleventh international conference on progress in vaccination against cancer (PIVAC-11), 10–13 October 2011, Copenhagen, DenmarkCancer Immunology, Immunotherapy, 2012
- The Two Faces of Interferon-γ in CancerClinical Cancer Research, 2011
- Impact of Clinical and Pathologic Features on Tumor-Infiltrating Lymphocyte Expansion from Surgically Excised Melanoma Metastases for Adoptive T-cell TherapyClinical Cancer Research, 2011
- Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer ImmunotherapyClinical Cancer Research, 2011
- CD8+ Enriched “Young” Tumor Infiltrating Lymphocytes Can Mediate Regression of Metastatic MelanomaClinical Cancer Research, 2010
- Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hostsJournal of Experimental Medicine, 2010
- Adoptive immunotherapy of cancer using CD4+ T cellsCurrent Opinion in Immunology, 2009
- The known unknowns of antigen processing and presentationNature Reviews Immunology, 2008
- Treatment of Metastatic Melanoma with Autologous CD4+ T Cells against NY-ESO-1New England Journal of Medicine, 2008
- The Three Es of Cancer ImmunoeditingAnnual Review of Immunology, 2004